Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.795
-0.065 (-3.49%)
At close: Sep 25, 2026, 4:00 PM EDT
1.890
+0.095 (5.29%)
After-hours: Sep 25, 2026, 7:59 PM EDT
Lexicon Pharmaceuticals Employees
Lexicon Pharmaceuticals had 81 employees as of December 31, 2025. The number of employees decreased by 22 or -21.36% compared to the previous year.
Employees
81
Change (1Y)
-22
Growth (1Y)
-21.36%
Revenue / Employee
$511,963
Profits / Employee
-$754,519
Market Cap
798.70M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 81 | -22 | -21.36% |
| Dec 31, 2024 | 103 | -182 | -63.86% |
| Dec 31, 2023 | 285 | 150 | 111.11% |
| Dec 31, 2022 | 135 | 48 | 55.17% |
| Dec 31, 2021 | 87 | 9 | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Geron | 258 |
| 4D Molecular Therapeutics | 196 |
| Solid Biosciences | 121 |
| Candel Therapeutics | 55 |
| Avalo Therapeutics | 33 |
| Achieve Life Sciences | 28 |
| Immix Biopharma | 21 |
LXRX News
- 11 days ago - Lexicon Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 15 days ago - Lexicon Pharmaceuticals Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 16 days ago - Lexicon Pharmaceuticals Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 24 days ago - Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - Lexicon announces results from post hoc analysis of SOLOIST-WHF trial - TheFly
- 25 days ago - Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure - GlobeNewsWire
- 4 weeks ago - Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851 - TheFly
- 4 weeks ago - Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851 - GlobeNewsWire